Le Lézard
Classified in: Health
Subjects: SVY, PET

Veterinary Chemistry Analyzers Market Size Worth $1.3 Billion by 2025: Grand View Research, Inc.


SAN FRANCISCO, June 7, 2018 /PRNewswire/ --

The global veterinary chemistry analyzers market size is expected to reach USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Rising animal healthcare expenditure and increasing pet ownership are some of the major factors contributing to the growth of the market.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Increasing incidence of zoonotic diseases is one of the key trends escalating market growth. According to an article published in the Centers for Disease Control and Prevention (CDC) in 2017, scientists estimated that 3 out of every 4 emerging infectious diseases in people are transmitted through animals, and more than 6 out of every 10 known infectious diseases in people are transmitted through animals.

Increasing demand for animal proteins is leading to a global rise in livestock production and increase in exports of animal products. Rising disposable income and changing lifestyles are stirring up the demand for animal-derived food products.

According to the American Pet Products Association (APPA), the U.S. pet food sales doubled to USD 22 billion from 2000 to 2014 and are expected to rise at a CAGR of 2.5%. According to Mintel, in 2014, 79.0% of the U.S. pet owners considered the quality of pet food products is as important as their own.

Browse full research report with TOC on "Veterinary Chemistry Analyzer Market Analysis Report By Type (Benchtop, Portable), By Product, By Application (Blood Chemistry, Glucose Monitoring, Urinalysis, Blood Gas Analysis), By End-Use, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/veterinary-chemistry-analyzer-market

Further Key Findings From the Report Suggest: 


Browse related reports by Grand View Research: 

Grand View Research has segmented the global veterinary chemistry analyzers market on the basis of type, product, application, end-use, and region: 

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com


SOURCE Grand View Research, Inc.


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: